SCHEMBL19502218

SCHEMBL19502218

Brc1cccc2c1oc1cccc(Br)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.41
▸ CDC14B O60729 1/20 0.40
▸ CDC14A Q9UNH5 1/20 0.40
▸ MAOA P21397 8/20 0.39
▸ AHR P35869 3/20 0.39
▸ EGFR P00533 1/20 0.39
▸ KDM5A P29375 1/20 0.34
▸ CYP19A1 P11511 2/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29805226 1.00 LOXL2 (0.41) LOXL2CDC14BCDC14AMAOAAHR
SCHEMBL20033067 0.84 TTR (0.37) LOXL2CDC14BCDC14AMAOAAHR
SCHEMBL22195636 0.84 AHR (0.59) CDC14BCDC14AMAOAAHREGFR
SCHEMBL24343638 0.84 MAOA (0.59) LOXL2MAOAEGFRKDM5AMAPT
SCHEMBL30761751 0.84 TTR (0.37) LOXL2CDC14BCDC14AMAOAAHR
SCHEMBL23406933 0.84 ALOX5 (0.41) CDC14BCDC14AMAOAAHRKDM5A
SCHEMBL31385571 0.84 ALOX5 (0.41) CDC14BCDC14AMAOAAHRKDM5A
SCHEMBL29450777 0.84 AHR (0.59) CDC14BCDC14AMAOAAHREGFR
SCHEMBL25056598 0.84 MAOA (0.54) LOXL2CDC14BCDC14AMAOAEGFR
SCHEMBL23406935 0.84 CDC14B (0.46) LOXL2CDC14BCDC14AMAOAAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027053-A Compound, organic light-emitting device and display device 阜阳欣奕华材料科技有限公司 2024-05-14 — — CN disclosed
US-20190165282-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2019-05-30 — — US disclosed
US-9938287-B1 Blue fluorescence dopant compound and organic electroluminescent device using the same NANJING TOPTO MATERIALS CO.,LTD. (CN) 2018-04-10 — — US disclosed
CN-107880055-A A kind of blue-fluorescence dopant and the organic electroluminescence device comprising this material 南京高光半导体材料有限公司 2018-04-06 — — CN disclosed
WO-2017178311-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2017-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165282-A1 HETEROCYCLIC COMPOUNDS COMPRISING DIBENZOFURAN AND/OR DIBENZOTHIOPHENE STRUCTURES DDT, NUDT1, ETFB LOXL2 2645/4885CDC14B 3810/4885CDC14A 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback